Iodine-125 Episcleral Plaque Brachytherapy for AJCC T4 Posterior Uveal Melanoma: Clinical Outcomes in 158 Patients

BACKGROUND/AIMS: The aim of this study is to report the burden of ocular morbidity following iodine-125 episcleral plaque brachytherapy (EPBT) in the treatment of American Joint Committee on Cancer (AJCC) T4-staged posterior uveal melanoma (PUM). METHODS: Clinical records of patients with T4-staged...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Ocul Oncol Pathol
Main Authors: King, Benjamin A., Awh, Caroline, Gao, Brad T., Wang, Jiajing, Kocak, Mehmet, Morales-Tirado, Vanessa M., Ballo, Matthew T., Wilson, Matthew W.
Formato: Artigo
Idioma:Inglês
Publicado: S. Karger AG 2019
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6751460/
https://ncbi.nlm.nih.gov/pubmed/31559245
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000495249
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares